Publication | Closed Access

Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01)

Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicineNeoadjuvant TreatmentSurgeryHops-br 01Phase 2Cancer TreatmentOncologyRadiation OncologyCancer Research